Pyxis Oncology, Inc. (PYXS)
1.15
+0.06
(+5.50%)
USD |
NASDAQ |
Dec 31, 16:00
1.13
-0.02
(-1.74%)
After-Hours: 20:00
Pyxis Oncology Free Cash Flow: -72.45M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -15.78M |
| Pfizer Inc. | 10.38B |
| Ironwood Pharmaceuticals, Inc. | 67.65M |
| Akebia Therapeutics, Inc. | 32.17M |
| Xtant Medical Holdings, Inc. | 5.123M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.28M |
| Cash from Investing (Quarterly) | 11.47M |
| Cash from Financing (Quarterly) | -0.008M |
| Free Cash Flow Per Share (Quarterly) | -0.2124 |
| Free Cash Flow to Equity (Quarterly) | -12.90M |
| Free Cash Flow to Firm (Quarterly) | -13.29M |
| Free Cash Flow Yield | -102.8% |